Cargando…
PROLONGED COVID-19 IN PATIENTS TREATED WITH RITUXIMAB
Autores principales: | WEBER, ANDREW, AVIV, RACHEL, SINGAS, EFFIE |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American College of Chest Physicians. Published by Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8503047/ http://dx.doi.org/10.1016/j.chest.2021.07.297 |
Ejemplares similares
-
INCREASED RISK OF MECHANICAL VENTILATION AND DEATH IN PATIENTS WITH COVID-19 RECENTLY TREATED WITH RITUXIMAB
por: MILES, B., et al.
Publicado: (2022) -
PROLONGED COVID-19 INFECTION IN AN IMMUNOSUPPRESSED PATIENT TREATED WITH CASIRIVIMAB/IMDEVIMAB
por: TOOR, SUBHAN A, et al.
Publicado: (2022) -
PATIENT ON RITUXIMAB CONTRACTING COVID-19 VIRUS AFTER VACCINATION
por: KHAN, AWAB, et al.
Publicado: (2021) -
RELAPSE AND REMITTING COVID-19 INFECTIONS IN AN IMMUNOSUPPRESSED PATIENT ON CHRONIC RITUXIMAB INFUSIONS
por: GREWAL, SAHIB, et al.
Publicado: (2021) -
A VERY PROLONGED AND ULTIMATELY FATAL COURSE OF COVID-19 IN A PATIENT WITH LYMPHOMA
por: DULU, ALINA, et al.
Publicado: (2021)